US Focused Ultrasound Therapy Market Industry Trends and Forecast to 2034: Segmented by (Application, Technology, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
Market Dashboard
US · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the
full report.
Estimate 2024$128.3 MnPlaceholder estimate
Estimate 2025$138.3 Mn38.1% of the global market
Projected 2034$271.9 Mn 96.6%Adds $133.6 Mn over 9 forecast years
CAGR 2025–20347.8%Faster than 58% of 173 Medical Devices markets here
Key players5
US is 38.1% of the global market.
In North America, the largest is US (this report) at $138.3 Mn.
113 in the USSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 12 Nov 2026.
Formats
PDF, PPTX, XLSX
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
The US Focused Ultrasound Therapy Market Analysis Executive Summary
Focused ultrasound therapy uses sound waves guided by MRI to treat tremor, tumours and other conditions without cutting.
Key segments of the focused Ultrasound Therapy market include application (Neurological Disorders, Uterine Fibroids and Prostate) and technology (MR-Guided and Ultrasound-Guided).
US Focused Ultrasound Therapy market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.
US Focused Ultrasound Therapy Market Dynamics
Market Growth Drivers
An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the focused Ultrasound Therapy market.
Opportunity
Biomarker-guided treatment, earlier diagnosis and new device-based therapies give the focused Ultrasound Therapy market strong room to grow.
Market Restraints
Hard-to-reach brain targets, high failure rates in trials, side effects and high prices for new therapies hold back the focused Ultrasound Therapy market.
Competitive Landscape for Focused Ultrasound Therapy Market in US
The focused Ultrasound Therapy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Healthcare Policies and Regulatory Landscape for Focused Ultrasound Therapy Market in US
Focused Ultrasound Therapy in the US: rules, payment and research
The FDA clears or approves medical devices by risk class, through 510(k) clearance, De Novo classification or premarket approval (PMA).[1] Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).[2] ClinicalTrials.gov lists 113 studies on Focused Ultrasound Therapy that are recruiting, active or about to start in the US.[3]
[3]ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 12 Nov 2026.
Policy changes and Reimbursement scenario
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how focused Ultrasound Therapy products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in US.
2.2 Market Size, Growth Prospects and Key findings
3 Market Dynamics
3.1 Market Growth Drivers Analysis
3.2 Market Restraints Analysis
4 Market Segmentation
4.1 By Application
4.2 By Technology
4.3 By End User
5 By Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6 Competitive Landscape
6.1 Major Top Market Players Products in Pipeline
6.2 R&D Initiatives
6.3 Notable recent Deals
6.3.1 Strategic Divestments
6.3.2 Mergers & Acquisitions
6.3.3 Partnerships
6.3.4 Joint Ventures
7 Key Company Profiles
7.1 Insightec
7.2 Profound Medical
7.3 SonaCare Medical
7.4 EDAP TMS
7.5 Philips
8 Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
The focused Ultrasound Therapy market can be segmented based on various criteria, including application, technology and end user. Here's a breakdown of the market segmentation
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
Also active in this area, from free public records
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Beyond the market numbers
Research, trials and patients
What doctors and scientists are doing in Focused Ultrasound Therapy right now, from free public sources.
Sources:PubMed (US National Library of Medicine),
ClinicalTrials.gov,
World Bank.
Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
Public data, with sources
Focused Ultrasound Therapy in context
The US compared
Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[1]
Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[2]
People aged 65 and over: 18.4% of people (2025). World: 10.4% of people (2025).[3]
[1]World Bank Open Data, Health spending per person (US$ per person). Retrieved 17 Nov 2026.
How big is the Focused Ultrasound Therapy market in the US?
Placeholder estimate: about $138.3 Mn in 2025, rising to about $271.9 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Focused Ultrasound Therapy market in the US growing?
Placeholder estimate: about 7.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Focused Ultrasound Therapy market report cover?
The report splits the market by application (Neurological Disorders, Uterine Fibroids, Prostate, Bone Metastases), technology (MR-Guided, Ultrasound-Guided) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Focused Ultrasound Therapy market?
Key players include Insightec, Profound Medical, SonaCare Medical, EDAP TMS and Philips Healthcare.
What is driving the Focused Ultrasound Therapy market?
An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the focused Ultrasound Therapy market.
Who regulates Focused Ultrasound Therapy in the US?
The FDA clears or approves medical devices by risk class, through 510(k) clearance, De Novo classification or premarket approval (PMA). Source: US Food and Drug Administration. Checked 14 Nov 2026.
How is healthcare paid for in the US?
Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS). Source: Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
How many clinical trials on Focused Ultrasound Therapy are running in the US?
113 studies are recruiting, active or about to start in the US, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 12 Nov 2026.
How much research is published on Focused Ultrasound Therapy?
PubMed lists 137 papers on Focused Ultrasound Therapy added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.